Antiallergic Drugs

Antiallergic drugs are medications designed to prevent or relieve symptoms caused by allergic reactions, such as sneezing, itching, runny nose, or hives. They primarily work by blocking histamine—a chemical released by the immune system during an allergic response—through H1 receptor antagonism. Common types include first-generation (e.g., diphenhydramine) and second-generation antihistamines (e.g., loratadine, cetirizine), which differ in sedation effects and duration of action.

The most widely used active pharmaceutical ingredients (APIs) in antiallergic drugs include loratadine, cetirizine hydrochloride, fexofenadine, desloratadine, and levocetirizine. These compounds are preferred for their non-sedating profiles, long half-lives, and high selectivity for peripheral H1 receptors. They are formulated into tablets, syrups, capsules, and oral solutions for both over-the-counter and prescription use.

Key quality control parameters for antiallergic drug intermediates include chemical purity (assessed via HPLC or GC), residual solvent levels (per ICH Q3C guidelines), heavy metal content, moisture content (via Karl Fischer titration), and structural confirmation (using NMR or FTIR). Impurity profiling is critical to ensure intermediates meet pharmacopeial standards (e.g., USP, EP) before progressing to final API synthesis.

Generic antiallergic drugs must demonstrate bioequivalence to their branded counterparts, meaning they deliver the same active ingredient at the same rate and extent in the body. Regulatory agencies like the FDA require rigorous testing to confirm therapeutic equivalence. While excipients may differ slightly, clinical efficacy and safety profiles are generally comparable when sourced from reputable manufacturers adhering to pharmacopeial standards.